Aranki S F, Cohn L H
Harvard Medical School, Boston, USA.
J Crit Illn. 1995 Sep;10(9):591-6.
For patients with less severe coronary artery disease, particularly one- or two-vessel disease, initial therapy may be with either thrombolytics or angioplasty. In those with more extensive disease (three-vessel or left main artery disease or proximal left anterior descending artery stenosis), bypass grafting can significantly reduce mortality. However, a patient's risk profile markedly influences outcome regardless of the procedure performed. Because angioplasty achieves incomplete revascularization, patients may need repeated angiography or revascularization, or they may have recurrent angina. If bypass graft disease is prevented, surgery may be effective for up to 20 years.
对于冠状动脉疾病不太严重的患者,尤其是单支或双支血管病变患者,初始治疗可以是溶栓治疗或血管成形术。对于病变范围更广的患者(三支血管病变、左主干动脉病变或左前降支近端狭窄),冠状动脉搭桥术可显著降低死亡率。然而,无论进行何种手术,患者的风险状况都会显著影响治疗结果。由于血管成形术不能实现完全血管重建,患者可能需要重复进行血管造影或血管重建,或者可能会复发心绞痛。如果能预防搭桥血管病变,手术效果可能长达20年。